Ask AI
Latest CAR T Advances
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma

Released: September 03, 2025

Activity

Progress
1
Course Completed

In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myeloma including the latest evidence from long-term clinical trial follow-up and real-world data, plus new data with CAR T-cell therapies in new lymphoma settings and novel CAR T-cell therapies currently under development for multiple myeloma.

  • Lymphomas
    • DLBCL: Real-world outcomes post axi-cel, CAR T vs autologous HSCT
    • FL: Tisa-cel (ELARA), axi-cel (ZUMA-5)
    • MZL: Liso-cel (TRANSCEND FL)
    • MCL: Real-world outcomes post brexu-cel
    • CLL: Liso-cel (TRANSCEND CLL 004)
  • Multiple Myeloma
    • Cilta-cel (CARTITUDE-1)
    • Anito-cel (iMMagine-1)
    • GC012F
    • Arlo-cel
    • BMS-986453
    • TriPRIL